Internal Medicine, Hematology & Oncology · Fullerton, CA
NPI
1003886698
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2151 N Harbor Blvd Ste 3200
Fullerton, CA, 92835
Phone (714) 446-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
1,382 services
Medicare patients, 2024
484
Average age 77
Drug cost, 2024
$5.0M
2,289 prescriptions
Company payments, 2025
$2,484
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven W Kim was code 99214 (office e&m - established), 893 times for 388 patients. In total Steven W Kim billed 1,382 services in 20 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 893 | 388 | $102.96 | $92K |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 30 | $64.86 | $4,994 |
| 99215 Office E&M - Established | Office | 66 | 59 | $146.75 | $9,685 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 64 | 47 | $13.12 | $840 |
| 99204 Office E&M - New | Office | 60 | 60 | $140.04 | $8,402 |
| 36415 Venipuncture Blood Collection | Office | 35 | 23 | $8.65 | $303 |
| 99222 Hospital E&M - Initial | Facility | 31 | 28 | $107.22 | $3,324 |
| 99213 Office E&M - Established | Office | 28 | 25 | $68.62 | $1,921 |
| 99443 Telephone Services | Office | 27 | 24 | $104.96 | $2,834 |
| 99205 Office E&M - New | Office | 23 | 23 | $178.19 | $4,098 |
| 99442 Telephone Services | Office | 18 | 14 | $78.20 | $1,408 |
| 99223 Hospital E&M - Initial | Facility | 15 | 13 | $142.86 | $2,143 |
By year: 2022 $132K for 1,396 services; 2023 $146K for 1,583 services; 2024 $134K for 1,382 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 35 | 23 | $8.65 | $303 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven W Kim prescribed most often to Medicare patients was Hydroxyurea, with 150 prescriptions and refills. In total Steven W Kim wrote 2,289 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 150 | 372 | 45 | $4,895 |
| Eliquis Apixaban | 144 | 227 | 41 | $127K |
| Acyclovir Generic | 107 | 233 | 37 | $3,317 |
| Revlimid Lenalidomide | 94 | 94 | 17 | $1.3M |
| Prednisone Generic | 84 | 89 | 36 | $209 |
| Dexamethasone Generic | 71 | 87 | 33 | $1,136 |
| Gabapentin Generic | 71 | 117 | 25 | $888 |
| Ondansetron Hcl Generic | 64 | 64 | 48 | $867 |
| Tamoxifen Citrate Generic | 61 | 150 | 18 | $1,836 |
| Anastrozole Generic | 59 | 145 | 21 | $1,258 |
| Pantoprazole Sodium Generic | 59 | 121 | 19 | $451 |
| Potassium Chloride Generic | 56 | 99 | 18 | $934 |
| Allopurinol Generic | 56 | 70 | 21 | $286 |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | 44 | 97 | 13 | $15K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 44 | 44 | 38 | $450 |
Brand drugs: 560 claims; generic drugs: 1,729 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven W Kim $2,484 ($2,484 in general payments such as food, travel and fees) from 35 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $415.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $415 |
| Celgene Corporation BMY | 21 | $241 |
| Abbvie Inc. ABBV | 11 | $172 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $171 |
| Incyte Corporation INCY | 3 | $143 |
| Janssen Biotech, Inc. JNJ | 4 | $120 |
| Eisai Inc. 4523.T | 4 | $116 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $112 |
| Daiichi Sankyo Inc. 4568.T | 4 | $106 |
| Lilly USA, LLC LLY | 4 | $80.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.